
As JPMorgan madness subsides, Democrats will unveil a legislative package to address drug price hikes
On the night before the start of JP Morgan — a conference where biopharma executives big and small waxed lyrical about innovation, adorned with name badges featuring a gold DNA capsule — President Donald Trump tweeted his displeasure that drugmakers were not honoring their promises to rein in prices. He wasn’t wrong. Data suggest drugmakers have returned to business as usual. And now, after Democrats clawed back control of the House, they’re expected to unveil a legislative package today to address what the White House has so far attempted in vain to do: cut prices for prescription drugs.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.